International Clinical Trial: An randomnized, open-label, multicenter, active-controlled study to assess the efficacy and safety of Denosumab compared with Risedronate in glucocorticoid-treated individuals with bone lossE

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011845) titled 'An randomnized, open-label, multicenter, active-controlled study to assess the efficacy and safety of Denosumab compared with Risedronate in glucocorticoid-treated individuals with bone lossE' on April 14.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT

Primary Sponsor: Ajou University Hospital

Condition:

Diseases of the musculoskeletal system and connective tissue

Intervention: Drug : 1. Treatment Group: Denosumab (Obodence(R) or Prolia(R)) 60 mg, administered subcutaneously twice at 6-month intervals (Day 1 a...